{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T21:08:53Z","timestamp":1791493733806,"version":"4.3.4"},"reference-count":85,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2019,6,27]],"date-time":"2019-06-27T00:00:00Z","timestamp":1561593600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004329","name":"Genzyme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0213329","type":"journal-article","created":{"date-parts":[[2019,6,27]],"date-time":"2019-06-27T13:30:08Z","timestamp":1561642208000},"page":"e0213329","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":15,"title":["Longitudinal study on ocular manifestations in a cohort of patients with Fabry disease"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0192-7487","authenticated-orcid":true,"given":"Langis","family":"Michaud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,6,27]]},"reference":[{"key":"ref1","article-title":"Fabry Disease: Perspectives from 5 Years of FOS","author":"M Fuller","year":"2006"},{"issue":"9647","key":"ref2","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0140-6736(08)61589-5","article-title":"Fabry's disease","volume":"372","author":"YA Zarate","year":"2008","journal-title":"Lancet"},{"issue":"2","key":"ref3","first-page":"4","article-title":"A Review of Fabry Disease","volume":"23","author":"B Chan","year":"2018","journal-title":"Skin Therapy Lett"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s10545-006-0484-8","article-title":"The Dutch Fabry cohort: diversity of clinical manifestations and Gb3 levels","volume":"30","author":"AC Vedder","year":"2007","journal-title":"J Inherit Metab Dis"},{"issue":"11","key":"ref5","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1136\/jmg.38.11.750","article-title":"Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males","volume":"38","author":"KD MacDermot","year":"2001","journal-title":"J Med Genet"},{"issue":"3","key":"ref6","doi-asserted-by":"crossref","first-page":"e0120814","DOI":"10.1371\/journal.pone.0120814","article-title":"Ocular signs correlate well with disease severity and genotype in Fabry disease","volume":"10","author":"S Pitz","year":"2015","journal-title":"PLoS One"},{"issue":"11","key":"ref7","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1136\/jmg.38.11.769","article-title":"Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females","volume":"38","author":"KD MacDermot","year":"2001","journal-title":"J Med Genet"},{"issue":"1","key":"ref8","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/GIM.0b013e31802d8321","article-title":"Heterozygous Fabry women are not just carriers, but have a significant burden of disease and impaired quality of life","volume":"9","author":"RY Wang","year":"2007","journal-title":"Genet Med"},{"key":"ref9","unstructured":"Miller-Keane. Encyclopedia and Dictionary of Medicine, Nursing, and Allied Health, Seventh Edition. 2003."},{"issue":"4","key":"ref10","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.ymgme.2018.02.014","article-title":"Fabry disease revisited: Management and treatment recommendations for adult patients","volume":"123","author":"A Ortiz","year":"2018","journal-title":"Mol Genet Metab"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s10545-006-0196-0","article-title":"Manifestations of Fabry disease in placental tissue","volume":"29","author":"AC Vedder","year":"2006","journal-title":"J Inherit Metab Dis"},{"issue":"1\u20132","key":"ref12","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jns.2014.06.029","article-title":"Fabry's disease","volume":"344","author":"R El-Abassi","year":"2014","journal-title":"J Neurol Sci"},{"issue":"3","key":"ref13","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.1542\/peds.2004-1678","article-title":"Pediatric Fabry disease","volume":"115","author":"M Ries","year":"2005","journal-title":"Pediatrics"},{"key":"ref14","article-title":"Fabry Disease: Perspectives from 5 Years of FOS","author":"U Ramaswami","year":"2006"},{"issue":"5","key":"ref15","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1203\/PDR.0b013e318183f132","article-title":"Characterization of Fabry disease in 352 pediatric patients in the Fabry Registry","volume":"64","author":"RJ Hopkin","year":"2008","journal-title":"Pediatr Res"},{"issue":"6","key":"ref16","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0090-4295(96)00320-2","article-title":"High-flow priapism associated with Fabry's disease in a child: a case report and review of the literature","volume":"48","author":"MM Foda","year":"1996","journal-title":"Urology"},{"issue":"2","key":"ref17","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/j.1365-2133.2007.08002.x","article-title":"Fabry disease and the skin: data from FOS, the Fabry outcome survey","volume":"157","author":"CH Orteu","year":"2007","journal-title":"Br J Dermatol"},{"issue":"9","key":"ref18","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/j.1365-2362.2006.01702.x","article-title":"Hearing loss in Fabry disease: data from the Fabry Outcome Survey","volume":"36","author":"S Hegemann","year":"2006","journal-title":"Eur J Clin Invest"},{"issue":"3","key":"ref19","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1365-2362.2004.01309.x","article-title":"Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey","volume":"34","author":"A Mehta","year":"2004","journal-title":"Eur J Clin Invest"},{"issue":"6","key":"ref20","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1111\/j.1755-3768.1984.tb08444.x","article-title":"Corneal findings in a foetus with Fabry's disease","volume":"62","author":"A Tsutsumi","year":"1984","journal-title":"Acta Ophthalmol (Copenh)"},{"issue":"4","key":"ref21","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1001\/archopht.1979.01020010327008","article-title":"The ocular manifestations in Fabry's disease","volume":"97","author":"NA Sher","year":"1979","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"ref22","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.ajo.2005.11.053","article-title":"Corneal and conjunctival manifestations in Fabry disease: in vivo confocal microscopy study","volume":"141","author":"L Mastropasqua","year":"2006","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"ref23","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1442-9071.2005.00990.x","article-title":"Ophthalmological manifestations of Fabry disease: a survey of patients at the Royal Melbourne Fabry Disease Treatment Centre","volume":"33","author":"TT Nguyen","year":"2005","journal-title":"Clin Exp Ophthalmol"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s12886-016-0374-2","article-title":"Paediatric Fabry disease: prognostic significance of ocular changes for disease severity","volume":"16","author":"G Kalkum","year":"2016","journal-title":"BMC Ophthalmol"},{"key":"ref25","first-page":"335","article-title":"Ophthalmic Drugs Facts","author":"JD Bartlett","year":"2010"},{"key":"ref26","first-page":"249","article-title":"Fabry Disease Perspective from 5 years of FOS","author":"A Sodi","year":"2006"},{"issue":"3","key":"ref27","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1076\/opge.24.3.129.15609","article-title":"Ocular manifestations in Fabry disease: a survey of 32 hemizygous male patients","volume":"24","author":"C Orssaud","year":"2003","journal-title":"Ophthalmic Genet"},{"issue":"3","key":"ref28","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0002-9394(76)90496-7","article-title":"Ocular findings in mannosidosis","volume":"82","author":"AI Arbisser","year":"1976","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"ref29","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0039-6257(82)90159-X","article-title":"Ocular pathology of Fabry's disease in a hemizygous male following renal transplantation","volume":"26","author":"EM Riegel","year":"1982","journal-title":"Surv Ophthalmol"},{"issue":"2","key":"ref30","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1136\/bjo.2006.100602","article-title":"Ocular manifestations of Fabry's disease: data from the Fabry Outcome Survey","volume":"91","author":"A Sodi","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"207573","DOI":"10.1155\/2013\/207573","article-title":"Vascular tortuosities of the upper eyelid: a new clinical finding in fabry patient screening","volume":"2013","author":"L Michaud","year":"2013","journal-title":"J Ophthalmol"},{"issue":"5","key":"ref32","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1001\/archopht.1978.03910050421003","article-title":"Central retinal artery occlusion complicating Fabry's disease","volume":"96","author":"NA Sher","year":"1978","journal-title":"Arch Ophthalmol"},{"issue":"5","key":"ref33","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s10792-008-9252-0","article-title":"Subfoveal choroidal neovascularization in a patient with Fabry's disease","volume":"29","author":"A Sodi","year":"2009","journal-title":"Int Ophthalmol"},{"issue":"7","key":"ref34","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1136\/bjo.60.7.508","article-title":"Ocular findings in a case of fucosidosis","volume":"60","author":"MB Snodgrass","year":"1976","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"ref35","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0022-3476(69)80387-2","article-title":"Generalized gangliosidosis","volume":"75","author":"J O'Brien","year":"1969","journal-title":"J Pediatr"},{"issue":"4","key":"ref36","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3109\/13816810903148004","article-title":"Subclinical optic neuropathy in Fabry disease","volume":"30","author":"S Pitz","year":"2009","journal-title":"Ophthalmic Genet"},{"issue":"2","key":"ref37","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.1097\/OPX.0b013e31827ec7eb","article-title":"Fabry disease: a review of ophthalmic and systemic manifestations","volume":"90","author":"MD Sivley","year":"2013","journal-title":"Optom Vis Sci"},{"issue":"1","key":"ref38","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1136\/bjophthalmol-2016-310088","article-title":"Conjunctival lymphangiectasia associated with classic Fabry disease","volume":"102","author":"MD Sivley","year":"2018","journal-title":"Br J Ophthalmol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.pediatrneurol.2016.07.001","article-title":"Fabry Disease: A Disorder of Childhood Onset","volume":"64","author":"R Schiffmann","year":"2016","journal-title":"Pediatr Neurol"},{"issue":"4","key":"ref40","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ymgme.2009.11.001","article-title":"Baseline characteristics of patients enrolled in the Canadian Fabry Disease Initiative","volume":"99","author":"S Sirrs","year":"2010","journal-title":"Mol Genet Metab"},{"issue":"4","key":"ref41","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.ymgme.2014.01.014","article-title":"Outcomes of patients treated through the Canadian Fabry disease initiative","volume":"111","author":"SM Sirrs","year":"2014","journal-title":"Mol Genet Metab"},{"key":"ref42","article-title":"The effect of enzyme replacement therapy on clinical outcomes in paediatric patients with Fabry disease\u2014A systematic literature review by a European panel of experts","author":"M Spada","year":"2018","journal-title":"Mol Genet Metab"},{"issue":"2","key":"ref43","doi-asserted-by":"crossref","first-page":"77","DOI":"10.7326\/0003-4819-146-2-200701160-00148","article-title":"Agalsidase-beta therapy for advanced Fabry disease: a randomized trial","volume":"146","author":"M Banikazemi","year":"2007","journal-title":"Ann Intern Med"},{"issue":"6","key":"ref44","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/mus.10497","article-title":"Enzyme replacement therapy improves peripheral nerve and sweat function in Fabry disease","volume":"28","author":"R Schiffmann","year":"2003","journal-title":"Muscle Nerve"},{"issue":"3","key":"ref45","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s10545-014-9677-8","article-title":"Natural course of Fabry disease and the effectiveness of enzyme replacement therapy: a systematic review and meta-analysis: effectiveness of ERT in different disease stages","volume":"37","author":"SM Rombach","year":"2014","journal-title":"J Inherit Metab Dis"},{"issue":"11","key":"ref46","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1136\/jnnp.2008.143693","article-title":"Central nervous system involvement in Anderson-Fabry disease: a clinical and MRI retrospective study","volume":"79","author":"S Buechner","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"ref47","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ymgme.2018.04.008","article-title":"The beneficial effects of long-term enzyme replacement therapy on cardiac involvement in Japanese Fabry patients","volume":"124","author":"K Hongo","year":"2018","journal-title":"Mol Genet Metab"},{"issue":"1","key":"ref48","doi-asserted-by":"crossref","first-page":"e000277","DOI":"10.1136\/bmjresp-2018-000277","article-title":"Pulmonary involvement in Fabry disease: effect of plasma globotriaosylsphingosine and time to initiation of enzyme replacement therapy","volume":"5","author":"D Franzen","year":"2018","journal-title":"BMJ Open Respir Res"},{"issue":"2","key":"ref49","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ymgme.2017.05.001","article-title":"Favourable effect of early versus late start of enzyme replacement therapy on plasma globotriaosylsphingosine levels in men with classical Fabry disease","volume":"121","author":"M Arends","year":"2017","journal-title":"Mol Genet Metab"},{"issue":"Suppl 1","key":"ref50","first-page":"35","article-title":"2016 Annual Symposium\u2014Abstracts: Rome, Italy, September 2016","volume":"39","year":"2016","journal-title":"J Inherit Metab Dis"},{"issue":"5","key":"ref51","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1136\/jmedgenet-2017-104863","article-title":"Agalsidase alfa versus agalsidase beta for the treatment of Fabry disease: an international cohort study","volume":"55","author":"M Arends","year":"2018","journal-title":"J Med Genet"},{"issue":"8","key":"ref52","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1093\/ndt\/gfx319","article-title":"Fabry disease under enzyme replacement therapy-new insights in efficacy of different dosages","volume":"33","author":"J Kramer","year":"2018","journal-title":"Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association\u2014European Renal Association"},{"issue":"3","key":"ref53","doi-asserted-by":"crossref","first-page":"e0173358","DOI":"10.1371\/journal.pone.0173358","article-title":"Enzyme replacement therapy for Anderson-Fabry disease: A complementary overview of a Cochrane publication through a linear regression and a pooled analysis of proportions from cohort studies","volume":"12","author":"R El Dib","year":"2017","journal-title":"PLoS One"},{"key":"ref54","article-title":"Treatment in Fabry disease","author":"M Lopez Rodriguez","year":"2018","journal-title":"Rev Clin Esp"},{"key":"ref55","article-title":"Oral chaperone therapy migalastat for treating Fabry disease: enzymatic response and serum biomarker changes after one year","author":"J Muntze","year":"2018","journal-title":"Clinical pharmacology and therapeutics"},{"key":"ref56","first-page":"S219","article-title":"Efficacy of migalastat in a cohort of male patients with the classical form of Fabry disease in a phase 3 study","volume":"39","author":"D Germain","year":"2016","journal-title":"J Inherit Metab Dis"},{"key":"ref57","first-page":"S51","article-title":"Novel treatment for Fabry disease\u2014IV administration of plant derived alpha-gal-a enzyme safety and efficacy, 1 year experience","volume":"39","author":"R Schiffmann","year":"2016","journal-title":"J Inherit Metab Dis"},{"issue":"6","key":"ref58","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s10545-007-0708-6","article-title":"Depression in adults with Fabry disease: a common and under-diagnosed problem","volume":"30","author":"AL Cole","year":"2007","journal-title":"J Inherit Metab Dis"},{"issue":"5","key":"ref59","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.jpeds.2004.01.051","article-title":"Fabry disease in childhood","volume":"144","author":"RJ Desnick","year":"2004","journal-title":"J Pediatr"},{"issue":"4","key":"ref60","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1023\/A:1015511908710","article-title":"Quality of life of patients with Fabry disease","volume":"11","author":"KF Gold","year":"2002","journal-title":"Qual Life Res"},{"issue":"6","key":"ref61","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/01.gim.0000223545.63012.5a","article-title":"Comparison of health-related quality of life between heterozygous women with Fabry disease, a healthy control population, and patients with other chronic disease","volume":"8","author":"NJ Street","year":"2006","journal-title":"Genet Med"},{"issue":"1","key":"ref62","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s10545-017-0095-6","article-title":"Phenotype, disease severity and pain are major determinants of quality of life in Fabry disease: results from a large multicenter cohort study","volume":"41","author":"M Arends","year":"2018","journal-title":"J Inherit Metab Dis"},{"issue":"4","key":"ref63","doi-asserted-by":"crossref","first-page":"25","DOI":"10.15353\/cjo.74.550","article-title":"Improved ways to screen for patients with Fabry disease, involving optometry in a multidisciplinary approach","volume":"74","author":"L Michaud","year":"2012","journal-title":"Can J Optom"},{"issue":"6","key":"ref64","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1136\/bjo.87.6.690","article-title":"A comparison of perimetric results with the Medmont and Humphrey perimeters","volume":"87","author":"J Landers","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"724546","DOI":"10.1155\/2014\/724546","article-title":"Corneal biomechanical properties in different ocular conditions and new measurement techniques","volume":"2014","author":"N Garcia-Porta","year":"2014","journal-title":"ISRN ophthalmology"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.2147\/OPTH.S168032","article-title":"Assessment of corneal hysteresis measured by the ocular response analyzer as a screening tool in patients with glaucoma","volume":"12","author":"JA Schweitzer","year":"2018","journal-title":"Clin Ophthalmol"},{"issue":"5","key":"ref67","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1755-3768.2010.02085.x","article-title":"Corneal hysteresis in mucopolysaccharidosis I and VI","volume":"90","author":"KT Fahnehjelm","year":"2012","journal-title":"Acta Ophthalmol"},{"issue":"12","key":"ref68","doi-asserted-by":"crossref","first-page":"7862","DOI":"10.1167\/iovs.12-10610","article-title":"Analysis of higher-order aberrations in a large clinical population","volume":"53","author":"A Hartwig","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"ref69","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jcrs.2009.09.026","article-title":"Wave aberration of human eyes and new descriptors of image optical quality and visual performance","volume":"36","author":"M Lombardo","year":"2010","journal-title":"J Cataract Refract Surg"},{"issue":"3","key":"ref70","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.ajhg.2016.07.008","article-title":"Rare Variants in MME, Encoding Metalloprotease Neprilysin, Are Linked to Late-Onset Autosomal-Dominant Axonal Polyneuropathies","volume":"99","author":"M Auer-Grumbach","year":"2016","journal-title":"American journal of human genetics"},{"issue":"2","key":"ref71","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1001\/archopht.121.2.240","article-title":"Corneal thickness and intraocular pressure in the Barbados eye studies","volume":"121","author":"B Nemesure","year":"2003","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"ref72","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000326896","article-title":"Corneal hysteresis in normal subjects and in patients with primary open-angle glaucoma and pseudoexfoliation glaucoma","volume":"46","author":"M Ayala","year":"2011","journal-title":"Ophthalmic research"},{"issue":"8","key":"ref73","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.jcrs.2007.04.021","article-title":"Corneal biomechanical properties in normal, post-laser in situ keratomileusis, and keratoconic eyes","volume":"33","author":"D Ortiz","year":"2007","journal-title":"J Cataract Refract Surg"},{"issue":"4","key":"ref74","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1475-1313.2011.00852.x","article-title":"Corneal biomechanical properties measured with the Ocular Response Analyser in a myopic population","volume":"31","author":"A Plakitsi","year":"2011","journal-title":"Ophthalmic Physiol Opt"},{"issue":"12","key":"ref75","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1016\/j.jcrs.2006.07.022","article-title":"Normal-eye Zernike coefficients and root-mean-square wavefront errors","volume":"32","author":"TO Salmon","year":"2006","journal-title":"J Cataract Refract Surg"},{"issue":"3\u20134","key":"ref76","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.joco.2015.11.002","article-title":"Higher order aberrations in a normal adult population","volume":"27","author":"H Hashemi","year":"2015","journal-title":"J Curr Ophthalmol"},{"issue":"Suppl 1","key":"ref77","first-page":"S7","article-title":"Canadian Ophthalmological Society evidence-based clinical practice guidelines for the management of glaucoma in the adult eye","volume":"44","year":"2009","journal-title":"Can J Ophthalmol"},{"issue":"1","key":"ref78","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0002-9394(00)00378-0","article-title":"Gas-permeable scleral contact lens therapy in ocular surface disease","volume":"130","author":"T Romero-Rangel","year":"2000","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"ref79","first-page":"173","article-title":"Switch from agalsidase beta to agalsidase alfa in the enzyme replacement therapy of patients with Fabry disease in Latin America","volume":"77","author":"D Ripeau","year":"2017","journal-title":"Medicina"},{"key":"ref80","first-page":"S214","article-title":"Switch of enzyme replacement therapy (ERT) in the Canadian Fabry Disease Initiative Study (CFDI): Intermediate follow-up at 3 and a half years","volume":"39","author":"C Morel","year":"2016","journal-title":"J Inherit Metab Dis"},{"key":"ref81","article-title":"Migalastat reverses cornea verticillata(vortex keratopathy) in Fabry disease","author":"O Goker-Alpan","year":"2019","journal-title":"Migalastat reverses cornea verticillata(vortex keratopathy) in Fabry disease"},{"issue":"1","key":"ref82","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1755-3768.2009.01554.x","article-title":"Corneal hysteresis measured with the Ocular Response Analyzer in normal and glaucomatous eyes","volume":"88","author":"O Abitbol","year":"2010","journal-title":"Acta Ophthalmol"},{"issue":"3","key":"ref83","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.sjopt.2016.05.001","article-title":"Corneal biomechanics in normal Saudi individuals","volume":"30","author":"K Al-Arfaj","year":"2016","journal-title":"Saudi J Ophthalmol"},{"issue":"4","key":"ref84","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.ophtha.2009.09.023","article-title":"Corneal biomechanical metrics and anterior segment parameters in mild keratoconus","volume":"117","author":"BM Fontes","year":"2010","journal-title":"Ophthalmology"},{"issue":"7","key":"ref85","first-page":"2674","article-title":"Optic Nerve capillaries blood oxygen investigation in Fabry's disease patients","volume":"56","author":"V Diaconu","year":"2015","journal-title":"Inv Opht Vis Sci"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0213329","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T02:16:58Z","timestamp":1588990618000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0213329"}},"subtitle":[],"editor":[{"given":"Gianni","family":"Virgili","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,6,27]]},"references-count":85,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019,6,27]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0213329","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/557207","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,27]]}}}